all report title image

OPIOID USE DISORDER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Opioid Use Disorder Market, By Product Type (Buprenorphine (Oral, Parenteral, Others), Naloxone (Parenteral and Others (Nasal Spray, etc.)), Naltrexone (Oral and Parenteral), Combination Drugs, and Methadone), By Route of Administration (Parenteral (Extended release Injection for Subcutaneous, Intramuscular), Oral (Sublingual Tablet, Sublingual Film, Suspension), and Others), By Dosage Form (Injections, Sublingual film, Sublingual or Buccal, Tablet, Suspension, and Others), By Availability (Prescription and Over the Counter), By Brand (Sublocade, Suboxone, Brixadi, Vivitrol, Zubsolv, NARCAN, and Others), By Age Group (Adult and Children), By Type (Branded and Generic), By Indication (Opioid Addiction and Pain Management (Acute, Chronic)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

  • Published In: 29 Apr, 2026
  • Code: CMI4597
  • Page number: 168
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033

Table of Contents (Version-2026)

  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Route of Administration
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Recent Test Launches
    • Product Launches/Approvals
    • Mergers, Acquisitions, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
    • PORTER’s Analysis
  4. Global Opioid Use Disorder Market, By Drug Type,

    2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Buprenorphine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Methadone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Naltrexone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
  5. Global Opioid Use Disorder Market, By Route of Administration,

    2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Parenteral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
  6. Global Opioid Use Disorder Market, By Distribution Channel, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Hospitals Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
  7. Global Opioid Use Disorder Market, By Region, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • U.S.
        • Canada
    • Latin America

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Route of Administration, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth,  By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Route of Administration, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth,  By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Route of Administration, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth,  By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Route of Administration, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021–2033, (US$ Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Company Profiles
      • Indivior PLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Alkermes
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Orexo AB
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Titan Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Mallinckrodt Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • BioDelivery Sciences International Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Viatris Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Hikma Pharmaceuticals PLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Camurus AB
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sun Pharmaceutical Industries Ltd.
        •  Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Amneal Pharmaceuticals LLC.
        •  Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Purdue Pharma LP
        •  Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Alvogen
        •  Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Faran Shimi Pharmaceutical
        •  Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Emplicure AB
        •  Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • MODASA Pharmaceuticals Pvt. Ltd.
        •  Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
    • Analysts’ Views
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 31 figures on “Global Opioid Use Disorder Market,” – Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.